From the Editor-in-Chief
Research on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
Forward Look
Minimizing Chemotherapy-Related Nausea and Vomiting | Scanning Disparities | Doing More With Less | Watch Your Mouth | Support Services Help Improve Patient Outcomes | What’s Next?
Your Cancer Guide
As the pandemic continues, cancer patients and survivors must weight fears of possible infection with their need to live fully.
by Hester Hill Schnipper
Caregiving With Confidence
When a loved one has advanced cancer, it’s common to mourn the loss that hasn’t happened yet.
by Karen J. Bannan
Policy Matters
Researchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.
by Kendall K. Morgan
Cancer survivors have higher rates of depression than the general population, but many don’t know help is available.
by Cameron Walker
Survivor Profile
Rob Paulsen has voiced hundreds of animated characters, but as he prepared to return to a beloved role, cancer threatened his livelihood.
by Bradley Jones
New therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
Healthy Habits
Health Nuts | Clearing the Fog
Q&A
Rebecca Dresser explores the history and burdens of clinical trials through the lens of a cancer survivor and medical ethicist.
by Marci A. Landsmann
Sound Advice
Experts answer questions about limiting exposure to the coronavirus, how to talk about a cancer recurrence with loved ones, and strategies for dealing with a loss of health insurance.
Get Involved
Rich Nardiello seeks to bring a smile to children with cancer.
Facts and Stats
Data collected from cancer registries help chart the national burden of cancer.
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Can discussion of health inequities lead to actionable change?
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
Learning Medicare’s ABCDs
donate to the AACR